Neutrophil-to-lymphocyte ratio predicts overall survival of patients with combined hepatocellular cholangiocarcinoma.
about
Neutrophil-to-lymphocyte ratio predicts overall survival of patients with combined hepatocellular cholangiocarcinoma.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Neutrophil-to-lymphocyte ratio ...... tocellular cholangiocarcinoma.
@en
Neutrophil-to-lymphocyte ratio ...... tocellular cholangiocarcinoma.
@nl
type
label
Neutrophil-to-lymphocyte ratio ...... tocellular cholangiocarcinoma.
@en
Neutrophil-to-lymphocyte ratio ...... tocellular cholangiocarcinoma.
@nl
prefLabel
Neutrophil-to-lymphocyte ratio ...... tocellular cholangiocarcinoma.
@en
Neutrophil-to-lymphocyte ratio ...... tocellular cholangiocarcinoma.
@nl
P2093
P2860
P356
P1433
P1476
Neutrophil-to-lymphocyte ratio ...... atocellular cholangiocarcinoma
@en
P2093
Shengping Li
Xiangming Lao
Xiaojun Lin
P2860
P304
P356
10.3892/OL.2018.7882
P50
P577
2018-01-26T00:00:00Z